DRAP introduce digital licensing system. The Drug Regulatory Authority of Pakistan (DRAP) has taken a major step forward in improving its regulatory services by digitalizing its licensing and approval process. Drastically shortening wait times for industry stakeholders. According to DRAP Chief Executive Officer Dr. Ubaidullah. The authority’s new digital approach has transformed what was once a lengthy. And cumbersome process often taking years into one that can now be completed in just a few days. This change has been driven by comprehensive reforms within the organization aimed at streamlining operations and boosting efficiency.
The overhaul of the system is part of DRAP’s broader push toward modernization and better service delivery. Under the digital framework, applications for licenses and approvals are now processed more quickly, with enhanced transparency and minimal manual paperwork. Officials say this shift will help ensure timely access to quality medicines and medical products for the public while encouraging industry growth.
BYD Launches New Electric Cars In Pakistan
Dr. Ubaidullah also highlighted that the government’s support has been instrumental in facilitating these reforms. And acknowledged ongoing efforts to further improve regulatory processes. The authority is also actively working with provincial and international partners to expand local capabilities. Including in vaccine manufacturing, to strengthen Pakistan’s healthcare infrastructure.
Industry observers believe that DRAP’s digitalized licensing system will improve ease of doing business in Pakistan’s pharmaceutical. And medical device sectors, giving companies quicker access to approvals and helping the country align with global regulatory practices. More details on specific features and timelines of the digital portal are expected to be announced by the authority in the coming days.